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Abstract
The aim of this research was to analyze the distribution of FTO and STAT6 genes polymorphism in patients with bronchial 
asthma (BA), associated with obesity (Ob) depending on the main disease severity degree. 
Materials and methods. The study included 117 patients 18–48 years old, divided in 3 groups. The main group (bronchial 
asthma, associated with obesity) included 57 patients, two groups of comparison – 30 patients with the diagnosis BA and a normal 
body weight, and 30 patients with obesity, but without the pathology of the bronchopulmonary system. 
The general genomic DNA was extracted from blood according to the standard protocol. The genetic typing was realized by 
the method of allele-specific amplification with the detection of results in the real time regime using TaqMan-probes, complementary 
to polymorphic parts of DNA. The detection of deletions in FTO and STAT 6 genes was realized by the method of polymerase chain 
reaction (PCR) using specific primers. 
Results. In the main group, among patients with BA and Ob, carriers of Т/Т genotype were 36,84 %, Т/А – 45,61 %, 
А/А – 17,55 % against 40 %, 60 % and 0 % respectively in PHP group by FTO gene. Carriers of С/С genotype in the main group were 
38,6 %, С/Т – 35,09 %, Т/Т – 26,31 % against 40 %, 55 % and 5 % respectively in PHP group by STAT6 gene. In the main group the 
light persisting BA was diagnosed in 20,0 % of cases, middle severity – in 60,0 % and severe – in 20,0 % of patients. In the group of 
comparison this disease severity was observed in 17,7 %, 66,5 % and 15,8 % of observations, respectively.
Conclusions. So, among patients with BA, associated with Ob with the middle and severe course of asthma the percent of 
heterozygous (Т/А) and mutant carriers (А/А) rs9939609 polymorphism of FTO gene is higher than at the light course. The analo-
gous situation is observed at the study of rs324011 polymorphism of STAT6 (C2892T) gene among this category of patients. So, the 
determination of FTO and STAT6 genes polymorphism in patients with BA, associated with Ob, can be considered as a marker of 
the more severe course of asthma. 
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1. Introduction 
Bronchial asthma (BA) it is a classic example of a multifactor pathology, realized at the 
interaction of numerous factors of environment and hereditary predisposition [1, 2]. Hereditary 
nature of the disease had been observed already in the last centuries and proved in XX century by 
hereditary forms of the disease and BA cases in twins. The genetic polymorphism is a base of the 
phenotypic difference between persons and may cause the hereditary predisposition to different 
nosologies [3, 4]. Today there is revealed a series of genes, involved in the asthma pathogenesis, 
that exist in different allele variants (single nucleotide polymorphisms) and favor BA appearance. 
The detection of “predisposition genes” may favor the purposeful primary prophylaxis in recep-
tive persons [5]. It was established, that at the combination of BA and obesity can be observed the 
heavier asthma course, worsening of disease control and inadequate response of patients to the 
treatment [6]. In patients with BA and obesity is formed the difficultly controlled phenotype with 
manifestations of a dose-dependence or resistance to inhalation CS (ICS) [7]. In the cross research 
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by L. Barclay was demonstrated, that the risk of hospitalization in patients with BA and obesity is 
5 times higher than in ones with a normal body mass [8]. The feature of BA course at the modern 
stage is the growth of specific weight of severe forms, including among youth that the high invalid-
ism and lethality are connected with [9, 10]. 
So, mechanisms of the main questions of both BA and obesity are interconnected and need 
a deeper study at both molecular and genetic level. The most spread method of studying BA genetic 
mechanisms is the search for disease associations with candidate genes polymorphism. Thus, there 
are found genes, responsible at the same time for asthma and obesity formation, and also for the 
synthesis of anti-inflammatory cytokines [11, 12]. It was established, that at obesity the risk of BA 
development is 1,4–2,2 times higher than at a normal body mass [13, 14]. Alongside with it the 
testing of genes-candidates demonstrated that none of them has a preferential value, because the 
genetic base of the disease has the multifactor nature [15].
2. Aim of research
To analyze distributions of rs9939609 polymorphism of FTO gene and rs324011 polymor-
phism of STAT6 gene in patients with bronchial asthma, associated with obesity, depending on the 
main disease severity degree. 
3. Materials and methods
The study included 117 patients 18–48 years old, divided in 3 clinical groups. The main 
group (bronchial asthma, associated with obesity – ІІ group) included 57 patients with mean 
age 38 years old. Among them were 30 women (52 %) and 27 men (48 %). At the same time two 
groups of comparison were formed: the first one (1 group) included 30 patients with the diagnosis 
BA and normal body mass, the third (III group) – 30 patients with Ob and without the pathology 
of the bronchopulmonary system (BMI ˃25,0 kg/m2). The control group consisted of 20 practically 
healthy persons (PHP). The mean duration of bronchial asthma was 8 years (2–15 years). The mean 
duration of obesity was 5 years. For setting the diagnosis, clinical course severity degree were 
used general clinical, laboratory and instrumental research methods based on GINA recommen-
dations (2011, 2014) [16], order of MHP of Ukraine No. 128 “About approval of clinical protocols 
of medical care for the specialty “Pulmonology” and “Unified clinical protocol of the primary, 
secondary (specialized) medical care “Bronchial asthma” No. 868 of 08.10.2013.
Genetic studies were realized on the base of the medical-genetic laboratory “Hermedtech”, 
Odessa city (license of MHP of Ukraine No. 196563 of 03.01.2013). The general genomic DNA 
was extracted from blood according to the standard protocol using the set for DNA extraction from 
clinical samples “AmpliPrime DNA-sorb-B” (made by AmpliSense, CSRI of epidemiology of MH 
RF, Russia). The genetic typing was realized by the method of allele-specific amplification with the 
detection of results in the real time regime using TaqMan-probes, complementary to polymorphic 
parts of DNA. The detection of deletions in FTO and STAT 6 genes was realized by the method of 
multiplex polymerase chain reaction (PCR) using specific primers. For FTO (T/A) gene the size of 
the amplicon for external primers – 321 pb, T-allele: 178 pb, A-allele: 201 pb. For STAT6 (C2892T) 
gene the size of the amplicon – 275 pb.
The obtained results of the study were analyzed using computer packages “STATISTICA” 
StatSoft Inc. and Excell XP Windows on a personal computer using parametric and non-paramet-
ric calculation methods. The distribution of genotypes in the studied sample was verified for the 
correspondence to Hardy-Weinberg equilibrium using the program Hardy-Weinberg Equilibrium 
Calculator for 2 Alleles.
4. Results of researches 
In the process of the research were complexly examined 117 patients, 18–48 years old, mean 
age was 33±5,2 y. (Table 1).
Among patients wasn’t observed any essential difference by gender. Thus, the male share 
was 49,2 %, female – 50,8 %. 
Table 1
Original Research Article:
full paper
(2017), «EUREKA: Health Sciences»
Number 5
27
Medicine and Dentistry
Clinical characteristics of patients
І group 
(BA), n=30
ІІ group
(BA+Ob), n=57
ІІІ group 
(Ob), n=30
Control group  
(PHP) n=20
Sex, n
M F M F M F M F
19 11 27 30 11 19 9 11
Mean age, years 28,5±4,63 38,52±3,25 29,52±7,77 30,33±5,33
The expression of Т/А polymorphism of FTO gene (rs9939609) and C2892T polymor-
phism of STAT6 (rs324011) gene was determined in 57 patients with bronchial asthma, combined 
with obesity, 30 patients with BA, 30 patients with Ob and 20 practically healthy persons. In the 
main group, carriers of Т/Т genotype were 36,84 %, Т/А – 45,61 %, А/А – 17,55 % against 40 %, 
60 % and 0 % respectively in PHP group by FTO gene. Carriers of С/С genotype in the main 
group were 38,6 %, С/Т – 35,09 %, Т/Т – 26,31 % against 40 %, 55 % and 5 % respectively in 
PHP group by STAT6 gene. 
Distributions of polymorphisms of selected genes in the main group (in patients with bron-
chial asthma, combined with obesity) are presented in Table 2. 
Table 2
Distributions of polymorphisms of FTO and STAT6 genes in the main group 
Genes
Absolute number, n % ІІ group (BA+Ob), n=57 χ
2 р р1
FTO
Alleles
Т 68 59,65
0,16 0,6922 ˃0,05
А 46 40,35
Genotypes
Т/Т 21 36,84
Т/А 26 45,61
А/А 10 17,55
STAT6
Alleles
С 64 56,14
4,71 0,03 ˂0,05
Т 50 43,86
Genotypes
С/С 22 38,60
С/Т 20 35,09
Т/Т 15 26,31
Note: р – reliability of differences of frequencies between genotypes by χ2 criterion; р1 – reliability of differences of parameters 
relative to Hardy-Weinberg scale of genotypes equilibrium
At the same time patients were distributed depending on BA severity degree and detection 
of FTO and STAT6 genes polymorphism (Table 3).
Table 3
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Clinical-phenotypic characteristic of patients with bronchial asthma, combined with obesity, depending on 
FTO and STAT6 genes polymorphism and asthma severity degree 
Genes
Patients with BA,  
combined with Ob (n=57)
Persisting  
light BA, n (%)
Persisting  
middle-severe BA, n (%)
Persisting  
severe BA, n (%)
FTO Genotypes
Т/Т 8(14,0) 9(15,8) 4(7,0)
Т/А 5(8,8) 14(24,6) 7(12,3)
А/А 1(1,7) 6(10,5) 3(5,3)
STAT6 Genotypes
С/С 4(7,0) 12(21,1) 6(10,5)
С/Т 4(7,0) 10(17,5) 6(10,5)
Т/Т 2(3,5) 8(14,0) 5(8,8)
Note: n – number of observations
In the main group the light persisting bronchial asthma was detected in 21,0 % of cases, 
middle severity – in 52,6 % and heavy – in 27,2 % of patients. 
5. Discussion of research results
Last time more and more studies are devoted to the genetic predisposition to certain dis-
eases. The last years’ studies, including the full genomic analysis demonstrated the essential 
connection between obesity and rs9939609 single nucleotide polymorphism in the first intron of 
FTO fat gene, fat mass and obesity associated [17, 18]. But mechanisms of this gene influence 
still insufficiently studied. Alongside with it among genes – candidates of BA and atopy the 
researchers’ attention is mostly fixed on the interleukin gene – 4 (IL-4). IL-4 is often called the 
“critical cytokine of inflammation”. It is used to think, that STAT-6 is activated by IL-4 and takes 
part in the induction of switching the synthesis of immunoglobulins to the synthesis of IgE and 
differentiation of Тh2-cells [19]. There was also demonstrated the dependence for BA in 53 % of 
cases and for obesity in 77 %, that indicates the genetic interconnection between these diseases. 
In parallel with it, at the association of BA and obesity the effect of “mutual complication” is 
fully realized that favors the heavier clinical course of asthma, worse control of the disease and 
bad patients’ response to the treatment [20, 21].
Considering general clinical characteristics of examined patients (sex, age, disease dura-
tion), it must be noted, that groups didn’t essentially differ by age structure. At the same time 
among patients wasn’t observed any essential difference by gender. Thus the male share was 
49,2 %, female – 50,8 %. 
Analyzing the obtained data, it can be seen, that among patients with bronchial asthma 
of middle severity, combined with obesity, the percent of heterozygous (Т/А) and mutant carriers 
of (А/А) of rs9939609 polymorphism of FTO gene is 3 times higher than at the light course and 
1,7 higher at the severe one. The analogous situation is observed at studying rs324011 polymor-
phism of STAT6 (C2892T) gene among this category of patients. The percent of heterozygous (С/Т) 
and mutant (Т/Т) carriers of rs324011 polymorphism of STAT6 among patients with bronchial 
asthma of middle severity, associated with obesity is 3 times higher than at the light course and 
1,8 times higher than at the severe one. 
It was revealed 45,61 % of heterozygous (Т/А) and 17,55 % of mutant (А/А) carriers of 
rs9939609 polymorphism of FTO gene and 35,09 % of heterozygous (С/Т) and 26,31 % of mu-
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tant (Т/Т) carriers of rs324011 polymorphism of STAT6 (C2892T) gene among patients with bron-
chial asthma and obesity. 
So, the determination of FTO and STAT6 genes polymorphism in patients with BA, asso-
ciated with Ob may be considered as a marker of the more severe asthma course, probably, with a 
worse response to the treatment. 
The prospect of further researches is the study of interconnections of FTO and STAT6 genes 
polymorphism in patients with bronchial asthma in the combination with obesity, with the effec-
tiveness of the basic treatment and asthma controllability. 
6. Conclusions
1. Among patients with bronchial asthma of middle severity and severe one, combined with 
obesity, the percent of heterozygous (Т/А) and mutant (А/А) carriers of rs9939609 polymorphism of 
FTO gene and heterozygous (С/Т) and mutant (Т/Т) carriers of rs324011 polymorphism of STAT6 
is higher than at the light course. 
2. The determination of FTO and STAT6 genes polymorphism in patients with BA, asso-
ciated with Ob may be considered as a marker of the more severe asthma course, probably, with a 
worse response to the treatment. 
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